Erratum: Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer (International Journal of Clinical Oncology, (2013) 18, 2, (293-304), 10.1007/s10147-012-0378-8);Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer

International Journal of Clinical Oncology

Volumn 18, Issue 2, 2013, Pages 293-304

  Isobe, Taro ^a   Aoyagi, Keishiro ^a   Koufuji, Kikuo ^a   Shirouzu, Kazuo ^a   Kawahara, Akihiro ^b   Taira, Tomoki ^b   Kage, Masayoshi ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY HOSPITAL   (Japan)

Author keywords

Clinicopathological factors; Gastric cancer; HIF 1 ; VEGF

Indexed keywords

CD34 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; STOMACH CANCER; SURVIVAL RATE; TUMOR INVASION; TUMOR VOLUME;

EID: 84880920150     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0467-8     Document Type: Erratum

References (52)

1. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533-543
2. Liao D, Johnson RS (2007) Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 26:281-290
3. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186
4. Gatenby RA, Kessler HB, Rosenblum JS et al (1988) Oxygen distribution in squamous cell carcinoma metastasis and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:531-538
5. Takahashi R, Tanaka S, Hiyama T et al (2003) Hypoxia-inducible factor 1 alpha expression and angiogenesis in gastrointestinal stromal tumor of stomach. Oncol Rep 10:797-802
6. Zhong H, Agani F, Baccala AA et al (1998) Increased expression of hypoxia-inducible factor 1 alpha in rat and human prostate cancer. Cancer Res 58:5280-5284
7. Chen WT, Huang CJ, Wu MT et al (2005) Hypoxia-inducible factor 1 alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor. Jpn J Clin Oncol 35:207-213
8. Mizokami K, Kakeji Y, Oda S et al (2006) Clinicopathological significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomas. J Surg Oncol 94:149-154
9. Yoshikawa T, Tsuburaya A, Miyagi Y et al (2006) Up-regulation of hypoxia-inducible factor 1 alpha and VEGF mRNAs in peritoneal dissemination of patients with gastric cancer. Anticancer Res 63:3849-3854
10. Sumiyoshi Y, Kakeji Y, Egashira A et al (2006) Overexpression of hypoxia-inducible factor 1 alpha and p53 is a marker for an unfavorable prognosis in gastric cancer. Clin Cancer Res 12:5112-5117
11. Stoeltzing O, McCarty MF, Wey JS et al (2004) Role of hypoxia-inducible factor 1 alpha in gastric cancer cell growth, angiogenesis, and vessel maturation. J Natl Cancer Inst 96:946-956
12. 2 is mediated by hypoxia-inducible factor 1. Cancer Res 63:2330-2334
13. Koshikawa N, Iyozumi A, Gassmann M (2003) Constitutive upregulation of hypoxia-inducible factor 1 alpha mRNA occurring in highly metastatic lung carcinoma cells leads to vascular endothelial growth factor overexpression upon hypoxic exposure. Oncogene 22:6717-6724
14. Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345-350
15. Saramaki OR, Savinainen KJ, Nupponen NN et al (2001) Amplification of hypoxia-inducible factor 1 alpha gene in prostate cancer. Cancer Genet Cytogenet 128:31-34
16. Ravi R, Mookerjee B, Bhujwalla ZM et al (2000) Regulation of tumor angiogenesis by p53 induced degradation of hypoxia-inducible factor 1α. Genes Dev 14:34-44
17. Kung AL, Wang S, Klco JM et al (2000) Suppression of tumor growth through disruption of hypoxia inducible transcription. Nat Med 6:1335-1340
18. Akakura N, Kobayashi M, Horiuchi I et al (2001) Constitutive expression of hypoxia-inducible factor-1 alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res 61:6548-6554
19. Dalgard CL, Lu H, Mohyedin A et al (2004) Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 380:419-424
20. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95:7987-7992
21. Talks KL, Turley H, Gatter KC et al (2000) The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 157:411-421
22. Chun YS, Kim MS, Park JW (2002) Oxygen-dependent and -independent regulation of HIF-1alpha. J Korean Med Sci 17:581-588
23. Shi YH, Fang WG (2004) Hypoxia-inducible factor-1 in tumor angiogenesis. World J Gastroenterol 10:1082-1087
24. Stroka DM, Burkhardt T, Desbaillets I et al (2001) HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15:2445-2453
25. Zagzag D, Zhong H, Scalzitti JM et al (2000) Expression of hypoxia-inducible factor 1 alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer (Phila) 88:2606-2618
26. Theodoropoulos VE, Lazaris A, Sofras F et al (2004) Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46:200-208
27. Bos R, Zhong H, Hanrahan CF et al (2001) Levels of hypoxia-inducible factor 1 alpha during breast carcinogenesis. J Natl Cancer Inst 93:309-314
28. Kuwa T, Kitada Y, Tanaka S et al (2003) Expression of hypoxia-inducible factor 1 alpha is associated with tumor vascularization in human colorectal carcinoma. Int J Cancer 105:176-181
29. Wiesener MS, Munchenhagen PM, Berger I et al (2001) Constitutive activation of hypoxia-inducible factor-1 alpha in clear cell renal carcinomas. Cancer Res 61:5215-5222
30. Birner P, Schindl M, Obermair A et al (2001) Expression of hypoxia-inducible factor 1 alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy. Clin Cancer Res 7:1661-1668
31. Buchler P, Reber HA, Buchler M et al (2003) Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 26:56-64
32. Japanese Gastric Cancer Association (2010) Japanese classification of gastric carcinoma, 14th edn. Kanehara, Tokyo
33. Livingston DM, Shivdasani R (2001) Toward mechanism-based cancer care. JAMA 285:588-593
34. Oskoski R Jr (2007) Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 62:179-213
35. Senger DR, Galli SJ, Dvorak AM et al (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985
36. Dvorak HF, Brown LF, Detmar M et al (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029-1039
37. Nagy JA, Masse EM, Herzberg KT et al (1995) Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55:360-368
38. Boocock CA, Charnock-Jones DS, Sharkey AM et al (1995) Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 87:506-516
39. Aoyagi K, Kouhuji K, Takeda J et al (2005) VEGF significance in peritoneal recurrence from gastric cancer. Gastric Cancer 8:155-163
40. Imaizumi T, Aoyagi K, Shirouzu K et al (2010) Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model. Surg Today 40:851-857
41. Chen C, Pore N, Behrooz A et al (2001) Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem 276:9519-9525
42. Jiang BH, Agani F, Passaniti A et al (1997) V-SRC induces expression of hypoxia-inducible factor 1(HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57:5328-5335
43. Laughner E, Taghavi P, Chiles K et al (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004
44. Mazure NM, Chen EY, Laderoute KR et al (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90:3322-3331
45. Aebersold DM, Burri P, Beer KT et al (2001) Expression of hypoxia-inducible factor 1 alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61:2911-2916
46. Matuyama T, Nakanishi K, Hayashi T et al (2005) Expression of hypoxia-inducible factor 1α in esophageal squamous cell carcinoma. Cancer Sci 96:176-182
47. Koukourakis MI, Giatromanolaki A, Skarlatos J et al (2001) Hypoxia-inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res 61:1830-1832
48. Beasley NJP, Leek R, Alam M et al (2002) Hypoxia-inducible factor HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62:2493-2497
49. Griffiths EA, Pritchard SA, Valentine HR et al (2007) Hypoxia-inducible factor 1 alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastroesophageal adenocarcinomas. Br J Cancer 96:95-103
50. Krishnamachary B, Berg-Dixon S, Kelly B et al (2003) Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 63:1138-1143
51. Yuri K, Qun L, Daniel Z et al (2009) Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity. Cancer Res 69:9271-9280
52. Wen WM, Alex AA (2009) Novel agents on the horizon for cancer therapy. CA Cancer 59:111-137